期刊文献+

卡泊三醇软膏两种不同用法治疗轻中度斑块状银屑病的疗效观察 被引量:3

下载PDF
导出
摘要 目的:观察卡泊三醇软膏分别按疗程和症状两种不同用药方法治疗轻中度斑块状银屑病的疗效及安全性。方法:斑块状银屑病患者60例,随机分为疗程治疗组及症状治疗组,每组30例,前者给予卡泊三醇软膏每日2次,共8周;后者给予卡泊三醇软膏每日2次,4周症状改善后改为每日1次,共8周,治疗前及治疗后第2、4、8周分别进行PASI评分,治疗前及治疗结束时测血钙浓度,判定疗效及记录不良反应。结果:经过8周观察,疗程治疗组治愈率和有效率分别为50.00%和76.67%,症状治疗组治愈率和有效率分别为23.33%和66.67%,两组治愈率有统计学差异,但有效率无统计学差异。疗程治疗组8例出现不良反应,对照组6例出现不良反应,均可耐受。结论:卡泊三醇治疗轻中度斑块状银屑病应足疗程用药。
出处 《皮肤性病诊疗学杂志》 2012年第4期222-224,共3页 Journal of Diagnosis and Therapy on Dermato-venereology
  • 相关文献

参考文献7

  • 1鲁智勇,郑捷.银屑病病情严重程度的评价方法[J].诊断学理论与实践,2009,8(3):360-362. 被引量:38
  • 2Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis [ J ]. Nature, 2007,445 ( 7130 ) : 866- 873.
  • 3无,郑志忠(执笔).中国银屑病治疗指南(2008版)[J].中华皮肤科杂志,2009,42(3):213-214. 被引量:194
  • 4Kragballe K, Noerrelund KL, Lui H, et al. Efficacy of once-daily treatment regimens with calcipotrioi/beta- methasone dipropionate ointment and calcipotrioi ointment in psoriasis vulgaris [ J ]. Br J Dermatol, 2004, 150 ( 6 ) : 1167-1173.
  • 5Cavicchini S, Brezzi A, Gasparini G, et al. Skin ultrastruc- ture after calcipotriol treatment: a transmission electron microscopic and freeze-fracture study on psoriatic patienl, s [ J]. Acta Derm Venereol, 1996,76 ( 3 ) : 186-189.
  • 6Ashcroft DM, Po AL, Williams HC, et al. Systematic re- view of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis [ J ]. BMJ, 2000,320 (7240) :963-967.
  • 7Guenther L, Van de Kerkhof PC, Snellman E, et al. Effica- cy and safety of a new combination of calcipotriol and be- tamethasone dipropionate ( once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial [ J ]. Br J Dermato1,2002,147 ( 2 ) : 316-323.

二级参考文献17

  • 1Glade CP, van Erp PE, Boezeman JB, et al. Multiparameter flow eytometry as a tool to evaluate antipsoriatic therapy[J]. Br J Dermatol, 1997, 137(3):367-375.
  • 2Piskin G, Heydendael VM, de Rie MA, et al. Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ[J]. Arch Dermatol Res, 2003, 294(12): 559-562.
  • 3de Rie MA, Hamerlinck F, Hintzen RQ, et al. Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis[J]. Arch Dermatol Res, 1991, 283(8): 533-534.
  • 4Borska L, Andrys C, Krejsek J, et al. Serum levels of the pro-inflammatory cytokine interleukin-12 and the antiinflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen[J]. Int J Dermatol, 2008, 47(8):800-805.
  • 5Garduno J, Bhosle M J, Balkrishnan R, et al. Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review[J]. J Dermatolog Treat, 2007, 18(4):223-242.
  • 6Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid[J]. Dermatologica, 1978, 157(4): 238-244.
  • 7Krueger GG, Feldman SR, Camisa C, et al. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?[J]. J Am Acad Dermatol, 2000, 43(2 Pt 1):281-285.
  • 8Feldman SR, Fleischer AB Jr, Reboussin DM, et al. The self-administered psoriasis area and severity index is valid and reliable[J]. J Invest Dermatol, 1996, 106(1): 183-186.
  • 9Finlay AY, Khan GK, Luscombe DK, et al. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis[J]. Br J Dermatol, 1990, 123(6): 751-756.
  • 10Hunt SM, McKenna SP, McEwen J, et al. A quantitative approach to perceived health status: a validation study[J]. J Epidemiol Community Health, 1980, 34(4): 281-286.

共引文献226

同被引文献47

  • 1陶建凤,郭一峰,陈仁贵.儿童von Zumbusch型脓疱性银屑病26例临床分析[J].临床皮肤科杂志,2005,34(1):17-19. 被引量:9
  • 2张立新,马琳.阿维A治疗12例儿童泛发性脓疱性银屑病疗效分析[J].临床皮肤科杂志,2007,36(9):594-595. 被引量:5
  • 3Tollefson MM, Crowson CS,McEvoy MT, et al. Incidence of psoriasis in children : a population-based study [ J ]. J Am Acad Dermatol, 2010, 62(6) :979-987.
  • 4Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population [ J 1- Arch Dermatol, 2007, 143 (12) : 1559-1565.
  • 5Icen M, Crowson CS, McEvoy MT, et al. Trends in inci- dence of adult-onset psoriasis over three decades : a popu- lation-based study[ J]. J Am Acad Dermatol, 2009, 60 (3) :394-401.
  • 6Fan X, Xiao FL, Yang S, et al. Childhood psoriasis: a study of 277 patients from China[ J]. J Eur Aead Derma- tol Venereol, 2007, 21 (6):762-765.
  • 7Boecardi D, Menni C, La Vecehia C, et al. Overweight and childhood psoriasis [ J]. Br J Dermatol, 2009, 161 (2) :484-486.
  • 8Zhu KJ, He SM, Zhang C,et al. Relationship of the body mass index and childhood psoriasis in a Chinese Han pop- ulation: a hospital-based study [ J]. J Dermatol, 2012, 39(2) :181-183.
  • 9Stefanaki C, Lagogianni E, Kontoehristopoulos G, et al. Psoriasis in children: a retrospective analysis [ J ]. J Eur Aead Dermatol Venereol, 2011 , 25 (4) :417-421.
  • 10Ko HC, Jwa SW, Song M, et al. Clinical course of gut- tate psoriasis : long-term follow-up study [ J ]. J Dermatol, 2010, 37(10): 894-899.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部